Global Gene Therapy Industry

NEW YORK, July 9, 2020 /PRNewswire/ --

Global Gene Therapy Market to Reach US$4.2 Billion by the Year 2027
Amid the COVID-19 crisis, the global market for Gene Therapy estimated at US$701.2 Million in the year 2020, is projected to reach a revised size of US$4.2 Billion by 2027, growing at a CAGR of 29.3% over the analysis period 2020-2027.Lentivirus, one of the segments analyzed in the report, is projected to grow at a 21.7% CAGR to reach US$130.1 Million by the end of the analysis period.After an early analysis of the business implications of the pandemic and its induced economic crisis, growth in the AAV segment is readjusted to a revised 24.9% CAGR for the next 7-year period. This segment currently accounts for a 13.5% share of the global Gene Therapy market.

Read the full report: https://www.reportlinker.com/p05817594/?utm_source=PRN

The U.S. Accounts for Over 26.8% of Global Market Size in 2020, While China is Forecast to Grow at a 36.3% CAGR for the Period of 2020-2027
The Gene Therapy market in the U.S. is estimated at US$188.2 Million in the year 2020. The country currently accounts for a 26.84% share in the global market. China, the world second largest economy, is forecast to reach an estimated market size of US$1.1 Billion in the year 2027 trailing a CAGR of 36.3% through 2027. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 23.2% and 26.7% respectively over the 2020-2027 period. Within Europe, Germany is forecast to grow at approximately 25.1% CAGR while Rest of European market (as defined in the study) will reach US$1.1 Billion by the year 2027.

RetroVirus & Gamma RetroVirus Segment Corners a 55.5% Share in 2020
In the global RetroVirus & Gamma RetroVirus segment, USA, Canada, Japan, China and Europe will drive the 28.6% CAGR estimated for this segment. These regional markets accounting for a combined market size of US$293.4 Million in the year 2020 will reach a projected size of US$1.7 Billion by the close of the analysis period. China will remain among the fastest growing in this cluster of regional markets. Led by countries such as Australia, India, and South Korea, the market in Asia-Pacific is forecast to reach US$662.2 Million by the year 2027, while Latin America will expand at a 30.1% CAGR through the analysis period. We bring years of research experience to this 16th edition of our report. The 248-page report presents concise insights into how the pandemic has impacted production and the buy side for 2020 and 2021. A short-term phased recovery by key geography is also addressed.

- Competitors identified in this market include, among others,

• American Gene Technologies Inc.
• Applied Genetic Technologies Corporation
• Benitec BioPharma
• BioMarin Pharmaceutical, Inc.
• bluebird bio, Inc.
• Brammer Bio
• Bristol-Myers Squibb Company
• Celgene Corporation
• Cellectis
• CELLforCURE
• CEVEC Pharmaceuticals GmbH
• Chiesi Farmaceutici SpA
• CSL Behring
• Gensight Biologics S.A.
• Gilead Sciences, Inc.
• GlaxoSmithKline PLC
• Human Stem Cells Institute PJSC (HSCI)
• Juno Therapeutics, Inc.
• Lonza Group Ltd.
• Novartis International AG
• Novasep Holding SAS
• Orchard Therapeutics Ltd.
• Oxford Biomedica plc
• REGENXBIO, Inc.
• Sanofi Genzyme
• Shanghai Sunway Biotech Co., Ltd.
• Shenzhen SiBiono GeneTech Co., Ltd.
• Shire PLC
• Taxus Cardium Pharmaceuticals Group
• Transgene SA
• Ultragenyx Pharmaceutical, Inc.
• uniQure NV
• Voyager Therapeutics, Inc.

Read the full report: https://www.reportlinker.com/p05817594/?utm_source=PRN

I. INTRODUCTION, METHODOLOGY & REPORT SCOPE

II. EXECUTIVE SUMMARY

1. MARKET OVERVIEW
Global Competitor Market Shares
Gene Therapy Competitor Market Share Scenario Worldwide (in %):
2019 & 2028
Impact of Covid-19 and a Looming Global Recession

2. FOCUS ON SELECT PLAYERS

3. MARKET TRENDS & DRIVERS

4. GLOBAL MARKET PERSPECTIVE
Table 1: Gene Therapy Global Market Estimates and Forecasts in
US$ Thousand by Region/Country: 2020-2027

Table 2: Gene Therapy Global Retrospective Market Scenario in
US$ Thousand by Region/Country: 2012-2019

Table 3: Gene Therapy Market Share Shift across Key Geographies
Worldwide: 2012 VS 2020 VS 2027

Table 4: Lentivirus (Vector) World Market by Region/Country in
US$ Thousand: 2020 to 2027

Table 5: Lentivirus (Vector) Historic Market Analysis by
Region/Country in US$ Thousand: 2012 to 2019

Table 6: Lentivirus (Vector) Market Share Breakdown of
Worldwide Sales by Region/Country: 2012 VS 2020 VS 2027

Table 7: AAV (Vector) Potential Growth Markets Worldwide in US$
Thousand: 2020 to 2027

Table 8: AAV (Vector) Historic Market Perspective by
Region/Country in US$ Thousand: 2012 to 2019

Table 9: AAV (Vector) Market Sales Breakdown by Region/Country
in Percentage: 2012 VS 2020 VS 2027

Table 10: RetroVirus & Gamma RetroVirus (Vector) Geographic
Market Spread Worldwide in US$ Thousand: 2020 to 2027

Table 11: RetroVirus & Gamma RetroVirus (Vector) Region Wise
Breakdown of Global Historic Demand in US$ Thousand: 2012 to
2019

Table 12: RetroVirus & Gamma RetroVirus (Vector) Market Share
Distribution in Percentage by Region/Country: 2012 VS 2020 VS
2027

Table 13: Modified Herpes Simplex Virus (Vector) World Market
Estimates and Forecasts by Region/Country in US$ Thousand: 2020
to 2027

Table 14: Modified Herpes Simplex Virus (Vector) Market
Historic Review by Region/Country in US$ Thousand: 2012 to 2019

Table 15: Modified Herpes Simplex Virus (Vector) Market Share
Breakdown by Region/Country: 2012 VS 2020 VS 2027

Table 16: Adenovirus (Vector) World Market by Region/Country in
US$ Thousand: 2020 to 2027

Table 17: Adenovirus (Vector) Historic Market Analysis by
Region/Country in US$ Thousand: 2012 to 2019

Table 18: Adenovirus (Vector) Market Share Distribution in
Percentage by Region/Country: 2012 VS 2020 VS 2027

Table 19: Other Applications (Vector) World Market Estimates
and Forecasts in US$ Thousand by Region/Country: 2020 to 2027

Table 20: Other Applications (Vector) Market Worldwide Historic
Review by Region/Country in US$ Thousand: 2012 to 2019

Table 21: Other Applications (Vector) Market Percentage Share
Distribution by Region/Country: 2012 VS 2020 VS 2027

III. MARKET ANALYSIS

GEOGRAPHIC MARKET ANALYSIS

UNITED STATES
Market Facts & Figures
US Gene Therapy Market Share (in %) by Company: 2019 & 2025
Market Analytics
Table 22: United States Gene Therapy Market Estimates and
Projections in US$ Thousand by Vector: 2020 to 2027

Table 23: Gene Therapy Market in the United States by Vector:
A Historic Review in US$ Thousand for 2012-2019

Table 24: United States Gene Therapy Market Share Breakdown by
Vector: 2012 VS 2020 VS 2027

CANADA
Table 25: Canadian Gene Therapy Market Estimates and Forecasts
in US$ Thousand by Vector: 2020 to 2027

Table 26: Canadian Gene Therapy Historic Market Review by
Vector in US$ Thousand: 2012-2019

Table 27: Gene Therapy Market in Canada: Percentage Share
Breakdown of Sales by Vector for 2012, 2020, and 2027

JAPAN
Table 28: Japanese Market for Gene Therapy: Annual Sales
Estimates and Projections in US$ Thousand by Vector for the
Period 2020-2027

Table 29: Gene Therapy Market in Japan: Historic Sales Analysis
in US$ Thousand by Vector for the Period 2012-2019

Table 30: Japanese Gene Therapy Market Share Analysis by
Vector: 2012 VS 2020 VS 2027

CHINA
Table 31: Chinese Gene Therapy Market Growth Prospects in US$
Thousand by Vector for the Period 2020-2027

Table 32: Gene Therapy Historic Market Analysis in China in US$
Thousand by Vector: 2012-2019

Table 33: Chinese Gene Therapy Market by Vector: Percentage
Breakdown of Sales for 2012, 2020, and 2027

EUROPE
Market Facts & Figures
European Gene Therapy Market: Competitor Market Share Scenario
(in %) for 2019 & 2025
Market Analytics
Table 34: European Gene Therapy Market Demand Scenario in US$
Thousand by Region/Country: 2020-2027

Table 35: Gene Therapy Market in Europe: A Historic Market
Perspective in US$ Thousand by Region/Country for the Period
2012-2019

Table 36: European Gene Therapy Market Share Shift by
Region/Country: 2012 VS 2020 VS 2027

Table 37: European Gene Therapy Market Estimates and Forecasts in US$ Thousand by Vector: 2020-2027

Table 38: Gene Therapy Market in Europe in US$ Thousand by
Vector: A Historic Review for the Period 2012-2019

Table 39: European Gene Therapy Market Share Breakdown by
Vector: 2012 VS 2020 VS 2027

FRANCE
Table 40: Gene Therapy Market in France by Vector: Estimates
and Projections in US$ Thousand for the Period 2020-2027

Table 41: French Gene Therapy Historic Market Scenario in US$
Thousand by Vector: 2012-2019

Table 42: French Gene Therapy Market Share Analysis by Vector:
2012 VS 2020 VS 2027

GERMANY
Table 43: Gene Therapy Market in Germany: Recent Past, Current
and Future Analysis in US$ Thousand by Vector for the Period
2020-2027

Table 44: German Gene Therapy Historic Market Analysis in US$
Thousand by Vector: 2012-2019

Table 45: German Gene Therapy Market Share Breakdown by Vector:
2012 VS 2020 VS 2027

ITALY
Table 46: Italian Gene Therapy Market Growth Prospects in US$
Thousand by Vector for the Period 2020-2027

Table 47: Gene Therapy Historic Market Analysis in Italy in US$
Thousand by Vector: 2012-2019

Table 48: Italian Gene Therapy Market by Vector: Percentage
Breakdown of Sales for 2012, 2020, and 2027

UNITED KINGDOM
Table 49: United Kingdom Market for Gene Therapy: Annual Sales
Estimates and Projections in US$ Thousand by Vector for the
Period 2020-2027

Table 50: Gene Therapy Market in the United Kingdom: Historic
Sales Analysis in US$ Thousand by Vector for the Period
2012-2019

Table 51: United Kingdom Gene Therapy Market Share Analysis by
Vector: 2012 VS 2020 VS 2027

SPAIN
Table 52: Spanish Gene Therapy Market Estimates and Forecasts
in US$ Thousand by Vector: 2020 to 2027

Table 53: Spanish Gene Therapy Historic Market Review by Vector
in US$ Thousand: 2012-2019

Table 54: Gene Therapy Market in Spain: Percentage Share
Breakdown of Sales by Vector for 2012, 2020, and 2027

RUSSIA
Table 55: Russian Gene Therapy Market Estimates and Projections
in US$ Thousand by Vector: 2020 to 2027

Table 56: Gene Therapy Market in Russia by Vector: A Historic
Review in US$ Thousand for 2012-2019

Table 57: Russian Gene Therapy Market Share Breakdown by
Vector: 2012 VS 2020 VS 2027

REST OF EUROPE
Table 58: Rest of Europe Gene Therapy Market Estimates and
Forecasts in US$ Thousand by Vector: 2020-2027

Table 59: Gene Therapy Market in Rest of Europe in US$ Thousand
by Vector: A Historic Review for the Period 2012-2019

Table 60: Rest of Europe Gene Therapy Market Share Breakdown by
Vector: 2012 VS 2020 VS 2027

ASIA-PACIFIC
Table 61: Asia-Pacific Gene Therapy Market Estimates and Forecasts
in US$ Thousand by Region/Country: 2020-2027

Table 62: Gene Therapy Market in Asia-Pacific: Historic Market
Analysis in US$ Thousand by Region/Country for the Period
2012-2019

Table 63: Asia-Pacific Gene Therapy Market Share Analysis by
Region/Country: 2012 VS 2020 VS 2027

Table 64: Gene Therapy Market in Asia-Pacific by Vector:
Estimates and Projections in US$ Thousand for the Period
2020-2027

Table 65: Asia-Pacific Gene Therapy Historic Market Scenario in
US$ Thousand by Vector: 2012-2019

Table 66: Asia-Pacific Gene Therapy Market Share Analysis by
Vector: 2012 VS 2020 VS 2027

AUSTRALIA
Table 67: Gene Therapy Market in Australia: Recent Past,
Current and Future Analysis in US$ Thousand by Vector for the
Period 2020-2027

Table 68: Australian Gene Therapy Historic Market Analysis in
US$ Thousand by Vector: 2012-2019

Table 69: Australian Gene Therapy Market Share Breakdown by
Vector: 2012 VS 2020 VS 2027

INDIA
Table 70: Indian Gene Therapy Market Estimates and Forecasts in
US$ Thousand by Vector: 2020 to 2027

Table 71: Indian Gene Therapy Historic Market Review by Vector
in US$ Thousand: 2012-2019

Table 72: Gene Therapy Market in India: Percentage Share
Breakdown of Sales by Vector for 2012, 2020, and 2027

SOUTH KOREA
Table 73: Gene Therapy Market in South Korea: Recent Past,
Current and Future Analysis in US$ Thousand by Vector for the
Period 2020-2027

Table 74: South Korean Gene Therapy Historic Market Analysis in
US$ Thousand by Vector: 2012-2019

Table 75: Gene Therapy Market Share Distribution in South Korea
by Vector: 2012 VS 2020 VS 2027

REST OF ASIA-PACIFIC
Table 76: Rest of Asia-Pacific Market for Gene Therapy: Annual
Sales Estimates and Projections in US$ Thousand by Vector for
the Period 2020-2027

Table 77: Gene Therapy Market in Rest of Asia-Pacific: Historic
Sales Analysis in US$ Thousand by Vector for the Period
2012-2019

Table 78: Rest of Asia-Pacific Gene Therapy Market Share
Analysis by Vector: 2012 VS 2020 VS 2027

LATIN AMERICA
Table 79: Latin American Gene Therapy Market Trends by
Region/Country in US$ Thousand: 2020-2027

Table 80: Gene Therapy Market in Latin America in US$ Thousand
by Region/Country: A Historic Perspective for the Period
2012-2019

Table 81: Latin American Gene Therapy Market Percentage
Breakdown of Sales by Region/Country: 2012, 2020, and 2027

Table 82: Latin American Gene Therapy Market Growth Prospects
in US$ Thousand by Vector for the Period 2020-2027

Table 83: Gene Therapy Historic Market Analysis in Latin
America in US$ Thousand by Vector: 2012-2019

Table 84: Latin American Gene Therapy Market by Vector:
Percentage Breakdown of Sales for 2012, 2020, and 2027

ARGENTINA
Table 85: Argentinean Gene Therapy Market Estimates and
Forecasts in US$ Thousand by Vector: 2020-2027

Table 86: Gene Therapy Market in Argentina in US$ Thousand by
Vector: A Historic Review for the Period 2012-2019

Table 87: Argentinean Gene Therapy Market Share Breakdown by
Vector: 2012 VS 2020 VS 2027

BRAZIL
Table 88: Gene Therapy Market in Brazil by Vector: Estimates
and Projections in US$ Thousand for the Period 2020-2027

Table 89: Brazilian Gene Therapy Historic Market Scenario in
US$ Thousand by Vector: 2012-2019

Table 90: Brazilian Gene Therapy Market Share Analysis by
Vector: 2012 VS 2020 VS 2027

MEXICO
Table 91: Gene Therapy Market in Mexico: Recent Past, Current
and Future Analysis in US$ Thousand by Vector for the Period
2020-2027

Table 92: Mexican Gene Therapy Historic Market Analysis in US$
Thousand by Vector: 2012-2019

Table 93: Mexican Gene Therapy Market Share Breakdown by
Vector: 2012 VS 2020 VS 2027

REST OF LATIN AMERICA
Table 94: Rest of Latin America Gene Therapy Market Estimates
and Projections in US$ Thousand by Vector: 2020 to 2027

Table 95: Gene Therapy Market in Rest of Latin America by
Vector: A Historic Review in US$ Thousand for 2012-2019

Table 96: Rest of Latin America Gene Therapy Market Share
Breakdown by Vector: 2012 VS 2020 VS 2027

MIDDLE EAST
Table 97: The Middle East Gene Therapy Market Estimates and
Forecasts in US$ Thousand by Region/Country: 2020-2027

Table 98: Gene Therapy Market in the Middle East by
Region/Country in US$ Thousand: 2012-2019

Table 99: The Middle East Gene Therapy Market Share Breakdown
by Region/Country: 2012, 2020, and 2027

Table 100: The Middle East Gene Therapy Market Estimates and
Forecasts in US$ Thousand by Vector: 2020 to 2027

Table 101: The Middle East Gene Therapy Historic Market by
Vector in US$ Thousand: 2012-2019

Table 102: Gene Therapy Market in the Middle East: Percentage
Share Breakdown of Sales by Vector for 2012,2020, and 2027

IRAN
Table 103: Iranian Market for Gene Therapy: Annual Sales
Estimates and Projections in US$ Thousand by Vector for the
Period 2020-2027

Table 104: Gene Therapy Market in Iran: Historic Sales Analysis
in US$ Thousand by Vector for the Period 2012-2019

Table 105: Iranian Gene Therapy Market Share Analysis by
Vector: 2012 VS 2020 VS 2027

ISRAEL
Table 106: Israeli Gene Therapy Market Estimates and Forecasts
in US$ Thousand by Vector: 2020-2027

Table 107: Gene Therapy Market in Israel in US$ Thousand by
Vector: A Historic Review for the Period 2012-2019

Table 108: Israeli Gene Therapy Market Share Breakdown by
Vector: 2012 VS 2020 VS 2027

SAUDI ARABIA
Table 109: Saudi Arabian Gene Therapy Market Growth Prospects
in US$ Thousand by Vector for the Period 2020-2027

Table 110: Gene Therapy Historic Market Analysis in Saudi
Arabia in US$ Thousand by Vector: 2012-2019

Table 111: Saudi Arabian Gene Therapy Market by Vector:
Percentage Breakdown of Sales for 2012, 2020, and 2027

UNITED ARAB EMIRATES
Table 112: Gene Therapy Market in the United Arab Emirates:
Recent Past, Current and Future Analysis in US$ Thousand by
Vector for the Period 2020-2027

Table 113: United Arab Emirates Gene Therapy Historic Market
Analysis in US$ Thousand by Vector: 2012-2019

Table 114: Gene Therapy Market Share Distribution in United
Arab Emirates by Vector: 2012 VS 2020 VS 2027

REST OF MIDDLE EAST
Table 115: Gene Therapy Market in Rest of Middle East: Recent
Past, Current and Future Analysis in US$ Thousand by Vector for
the Period 2020-2027

Table 116: Rest of Middle East Gene Therapy Historic Market
Analysis in US$ Thousand by Vector: 2012-2019

Table 117: Rest of Middle East Gene Therapy Market Share
Breakdown by Vector: 2012 VS 2020 VS 2027

AFRICA
Table 118: African Gene Therapy Market Estimates and
Projections in US$ Thousand by Vector: 2020 to 2027

Table 119: Gene Therapy Market in Africa by Vector: A Historic
Review in US$ Thousand for 2012-2019

Table 120: African Gene Therapy Market Share Breakdown by
Vector: 2012 VS 2020 VS 2027

IV. COMPETITION

Total Companies Profiled: 98
Read the full report: https://www.reportlinker.com/p05817594/?utm_source=PRN

About Reportlinker
ReportLinker is an award-winning market research solution. Reportlinker finds and organizes the latest industry data so you get all the market research you need - instantly, in one place.

Contact Clare: [email protected]   
US: (339)-368-6001
Intl: +1 339-368-6001

SOURCE Reportlinker

Related Links

www.reportlinker.com